» Articles » PMID: 12610117

Vaccinia Virus G7L Protein Interacts with the A30L Protein and is Required for Association of Viral Membranes with Dense Viroplasm to Form Immature Virions

Overview
Journal J Virol
Date 2003 Mar 1
PMID 12610117
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The vaccinia virus A30L protein is required for the association of electron-dense, granular, proteinaceous material with the concave surfaces of crescent membranes, an early step in viral morphogenesis. For the identification of additional proteins involved in this process, we used an antibody to the A30L protein, or to an epitope appended to its C terminus, to capture complexes from infected cells. A prominent 42-kDa protein was resolved and identified by mass spectrometry as the vaccinia virus G7L protein. This previously uncharacterized protein was expressed late in infection and was associated with immature virions and the cores of mature particles. In order to study the role of the G7L protein, a conditional lethal mutant was made by replacing the G7L gene with an inducible copy. Expression of G7L and formation of infectious virus was dependent on the addition of inducer. Under nonpermissive conditions, morphogenesis was blocked and viral crescent membranes and immature virions containing tubular elements were separated from the electron-dense granular viroplasm, which accumulated in large spherical masses. This phenotype was identical to that previously obtained with an inducible, conditional lethal A30L mutant. Additional in vivo and in vitro experiments provided evidence for the direct interaction of the A30L and G7L proteins and demonstrated that the stability of each one was dependent on its association with the other.

Citing Articles

The Vaccinia virion: Filling the gap between atomic and ultrastructure.

Mirzakhanyan Y, Gershon P PLoS Pathog. 2019; 15(1):e1007508.

PMID: 30615658 PMC: 6336343. DOI: 10.1371/journal.ppat.1007508.


Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.

Luteijn R, Drexler I, Smith G, Lebbink R, Wiertz E J Gen Virol. 2018; 99(6):790-804.

PMID: 29676720 PMC: 7614823. DOI: 10.1099/jgv.0.001034.


Topotecan is a potent inhibitor of SUMOylation in glioblastoma multiforme and alters both cellular replication and metabolic programming.

Bernstock J, Ye D, Gessler F, Lee Y, Peruzzotti-Jametti L, Baumgarten P Sci Rep. 2017; 7(1):7425.

PMID: 28785061 PMC: 5547153. DOI: 10.1038/s41598-017-07631-9.


Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.

Hyun S, Weisberg A, Moss B J Virol. 2017; 91(15).

PMID: 28490596 PMC: 5512257. DOI: 10.1128/JVI.00558-17.


Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4.

Jesus D, Moussatche N, McFadden B, Nielsen C, DCosta S, Condit R Virology. 2015; 481:1-12.

PMID: 25765002 PMC: 4437912. DOI: 10.1016/j.virol.2015.02.020.


References
1.
BOULTER E, Appleyard G . Differences between extracellular and intracellular forms of poxvirus and their implications. Prog Med Virol. 1973; 16:86-108. View

2.
Appleyard G, Hapel A, BOULTER E . An antigenic difference between intracellular and extracellular rabbitpox virus. J Gen Virol. 1971; 13(1):9-17. DOI: 10.1099/0022-1317-13-1-9. View

3.
Stokes G . High-voltage electron microscope study of the release of vaccinia virus from whole cells. J Virol. 1976; 18(2):636-43. PMC: 515590. DOI: 10.1128/JVI.18.2.636-643.1976. View

4.
Payne L . Significance of extracellular enveloped virus in the in vitro and in vivo dissemination of vaccinia. J Gen Virol. 1980; 50(1):89-100. DOI: 10.1099/0022-1317-50-1-89. View

5.
HILLER G, Weber K . Golgi-derived membranes that contain an acylated viral polypeptide are used for vaccinia virus envelopment. J Virol. 1985; 55(3):651-9. PMC: 255032. DOI: 10.1128/JVI.55.3.651-659.1985. View